Task Force’s PSA Proposal Prompts Calls For More Research On Prostate Cancer Diagnostics
This article was originally published in The Gray Sheet
Executive Summary
Overdiagnosis and overtreatment of prostate cancers that result from screening with prostate-specific antigen tests highlight the need for research on new diagnostics technologies, suggests a new draft statement from the U.S. Preventive Services Task Force.